Mutation

(redirected from Factor V Leiden mutation)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia.

MUTATION, French law. This term is synonymous with change, and is particularly applied to designate the change which takes place in the property of a thing in its transmission from one person to another; permutation therefore happens when, the owner of the thing sells, exchanges or gives it. It is nearly synonymous with transfer. (q.v.) Merl. Repert. h.t.

References in periodicals archive ?
Keywords: Factor V Leiden mutation, Recurrent pregnancy loss, PCR (Polymerase chain reaction).
Aortic arch thrombosis in a neonate with heterozygous carrier status of Factor V Leiden Mutation.
Individuals with Factor V Leiden mutation therefore have decreased deactivation of both FVa and FVIIIa and increased risk of thrombosis.
Guedon C, Le Cam-Duchez V, Lalaude O, Menard JF, Lerebours E, Borg JY: Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease.
The presence of the factor V Leiden mutation increases the risk of VTE and pregnancyrelated morbidity to 1/500.
Gurgey A, Balta G, Boyvat A: Factor V leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease.
Detection of the factor V Leiden mutation by a modified photocross-linking oligonucleotide hybridization assay.
They concluded that their study showed a significant increase in the prevalence of the factor V Leiden mutation, leading them to the conclusion that patients with factor V Leiden mutation have a predisposition for MI.
A woman between the ages of 28 and 45 with [genetic thrombophilia], such as the factor V Leiden mutation, and who also uses oral contraceptives has an increased risk of thrombosis, but she may ultimately manage to avoid having a thrombotic episode.
Eighteen patients consented to a prospective hypercoagulability evaluation that included assays for protein C, protein S, APC resistance, factor V Leiden mutation, anticardiolipin antibodies, antineutrophil cytoplasmic antibodies (ANCA), rheumatoid factor, antithrombin III, anti-smooth muscle antibody, and lupus anticoagulant panel.
American College of Medical Genetics consensus statement on factor V Leiden mutation testing.